Meningitis Vaccine Out of the Cold Chain: Brings Hope to Remote Areas in Africas
In a groudbreaking announcment made last week, the World Health Organization ruled that the MenAfriVac vaccine, which is already having a big impact in the "Meningitis Belt" of Africa, can be safely used even after four days without refrigeration.
Many vaccines require an expensive cold chain to keep the shots stable every step of the way. Removing the need for refrigeration at the final stage of delivery gives health workers a chance to reach remote regions without ice or expenisive equipment. This annoucment paves the way for other vaccines to be approved for use after heat exposure and is an important step towards increasing equitable access to vaccines.
Sabin's latest Gold Medal recipient contributed to the development of the MenAfriVac vaccine. Read more here.